Latest News

Huntington disease prevention trial shows creatine safe, slows progression

The first clinical trial of a drug intended to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most participants. In addition, neuroimaging showed a treatment-associated slowing of regional brain atrophy, evidence that creatine might slow the progression of presymptomatic disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Ten-hut: New discoveries on how military organization affects civilians

  • Dress for success: Research examines male influences on 'looking' middle class

  • Family members of victims pose a growing challenge for capital punishment

  • Despite academic achievement, pay gaps likely continue between the races

  • Life after prison: Ex-offenders' stigma management

  • The ABC's of animal speech: Not so random after all

  • Combined drugs, therapy most effective for severe nonchronic depression

  • White-matter deficits in users of codeine-containing cough syrups

  • Novel pathway for prevention of heart attack, stroke

  • ADHD children make poor decisions due to less differentiated learning processes

  •